Similarly, high levels of AXL protein were associated with resistance to ATR inhibition and treatment with AXL inhibitor R428 sensitized NSCLC cells to ATR inhibitors, VX-970 and AZD6738, resulting in significant DNA damage [59]. This evidence concerns the gene AXL and non-small cell lung carcinoma.